Welcome!
Jinhushen Biological Medical Science and Technology
M&A
Jinhushen Bio completes 67% acquisition with Tianjin Pharma, S shares offer price revised
The S shares offer price is revised from 89.3 US cents ($1.20) to 89.4 US cents due to a computation mistake.
March 27, 2021
M&A
Jinhushen Biological Medical Science and Technology to acquire 67% stake in Tianjin Zhong Xin’s controlling shareholder for undisclosed sum
As at Dec 20, TPH holds an interest of 42.8% of the total number of issued shares in the capital of Tianjin Zhong Xin.
December 21, 2020